- Home
- LPTX vs VIOT Comparison
LPTX vs VIOT Comparison
Compare LPTX & VIOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPTX
- VIOT
- Stock Information
- Founded
- LPTX 2011
- VIOT 2014
- Country
- LPTX United States
- VIOT China
- Employees
- LPTX N/A
- VIOT N/A
- Industry
- LPTX Biotechnology: Biological Products (No Diagnostic Substances)
- VIOT Consumer Electronics/Appliances
- Sector
- LPTX Health Care
- VIOT Consumer Discretionary
- Exchange
- LPTX Nasdaq
- VIOT Nasdaq
- Market Cap
- LPTX 119.6M
- VIOT 102.5M
- IPO Year
- LPTX N/A
- VIOT 2018
- Fundamental
- Price
- LPTX $0.48
- VIOT $1.61
- Analyst Decision
- LPTX Buy
- VIOT
- Analyst Count
- LPTX 3
- VIOT 0
- Target Price
- LPTX $8.50
- VIOT N/A
- AVG Volume (30 Days)
- LPTX 1.5M
- VIOT 92.8K
- Earning Date
- LPTX 03-17-2025
- VIOT 03-24-2025
- Dividend Yield
- LPTX N/A
- VIOT N/A
- EPS Growth
- LPTX N/A
- VIOT N/A
- EPS
- LPTX N/A
- VIOT N/A
- Revenue
- LPTX N/A
- VIOT $306,754,324.00
- Revenue This Year
- LPTX N/A
- VIOT N/A
- Revenue Next Year
- LPTX N/A
- VIOT N/A
- P/E Ratio
- LPTX N/A
- VIOT N/A
- Revenue Growth
- LPTX N/A
- VIOT N/A
- 52 Week Low
- LPTX $0.47
- VIOT $0.50
- 52 Week High
- LPTX $4.79
- VIOT $1.94
- Technical
- Relative Strength Index (RSI)
- LPTX 19.00
- VIOT 58.61
- Support Level
- LPTX $0.47
- VIOT $1.57
- Resistance Level
- LPTX $0.53
- VIOT $1.78
- Average True Range (ATR)
- LPTX 0.04
- VIOT 0.12
- MACD
- LPTX 0.07
- VIOT 0.03
- Stochastic Oscillator
- LPTX 7.42
- VIOT 67.31
About LPTX Leap Therapeutics Inc.
Leap Therapeutics Inc is in developing targeted antibody therapies for cancer treatment, focusing on inhibiting tumor-promoting pathways, targeting cancer-specific cell surface molecules, and activating the immune system against cancer cells. The company's lead program, DKN-01, targets Dickkopf-related protein 1 (DKK1) and is in clinical trials for esophagogastric, gynecologic, and colorectal cancers. Their second program, FL-301, targets Claudin18.2-expressing cells. Additionally, the company has two preclinical antibody programs, FL-302 and FL-501, aimed at developing transformative cancer treatments. Operating as a single segment, the company's sole focus is on developing innovative drugs to address unmet needs in cancer therapy. .
About VIOT Viomi Technology Co. Ltd
Viomi Technology Co Ltd along with its subsidiaries provides Internet of Things (IoT) enabled smart home products through its platform. It has developed an IoT Home platform, consisting of an ecosystem of IoT Home portfolio, and home water solutions, together with a suite of complementary consumable products and small appliances and others. Its product offerings include Smart kitchen products like refrigerators, oven steamers, dishwashers, and gas stoves, Other smart products such as air conditioning systems, washing machines, water heaters, smart water kettles, interactive smart screens and other smart devices, and Home water solutions include self-branded and Xiaomi-branded smart water purifiers.